HIGHLIGHTS
- who: Ying Guo and colleagues from the Department of Obstetrics and Gynecology, Maternity and Child Health Hospital of Qinhuangdao, Qinhuangdao, Hebei, China have published the research: Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer, in the Journal: Journal of Immunology Research of 18/05/2022
- what: This study is aimed at establishing a cisplatin response prediction model for OV on the basis of immune genes. The response scores estimated by the model showed favorable performance in discriminating cisplatin-response and nonresponse samples . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.